MAOA
Amine oxidase [flavin-containing] A
Protein Summary
Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT), norepinephrine and epinephrine. This gene is one of two neighboring gene family members that encode mitochondrial enzymes which catalyze the oxidative deamination of amines, such as dopamine, norepinephrine, and serotonin. Mutation of this gene results in Brunner syndrome. This gene has also been associated with a variety of other psychiatric disorders, including antisocial behavior. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Jul 2012]
- ENST00000338702
- ENSP00000340684
- ENSG00000189221
- ENST00000542639
- ENSP00000440846
- BRNRS
- MAO-A
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
|---|---|---|---|
drug | 0.99 | ||
kinase perturbation | 0.97 | ||
transcription factor perturbation | 0.97 | ||
gene perturbation | 0.91 | ||
pathway | 0.87 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 3593.29 (req: < 5)
Gene RIFs: 462 (req: <= 3)
Antibodies: 421 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 3593.29 (req: >= 5)
Gene RIFs: 462 (req: > 3)
Antibodies: 421 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 6
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 599
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drugs: 15